OmniAb, Inc. (OABI) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 37 days, typically, give or take 16 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Fri, Oct 30, 2026before open 30 8-K
Q2 FY2026Thu, Aug 6, 2026after close 37 8-K
Q1 FY2026Thu, May 7, 2026after close 37 8-K
Q4 FY2025Wed, Mar 4, 2026after close 63 8-K
Q3 FY2025Tue, Nov 4, 2025after close 35 8-K
Q2 FY2025Wed, Aug 6, 2025after close 37 8-K
Q1 FY2025Thu, May 8, 2025after close 38 8-K
Q4 FY2024Tue, Mar 18, 2025after close 77 8-K

What they guided beta

Q3 FY2026 "Document Exhibit 99.1 OmniAb Reports Third Quarter 2026 Financial Results and Business Highlights Raises Full Year 2026 Revenue and Cash Outlook on Continued Business Momentum Conference Call to Begin Today at 8:00 a.m. ET EMERYVILLE, Calif." exhibit
Q3 FY2026 "(October 30, 2026) – OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today reported financial results for the three and nine months ended September 30, 2026, provided operating and partner program progress, and updated 2026 financial guidance." exhibit
Q3 FY2026 "Research and development expense was $9.6 million for the third quarter of 2026, compared with $10.4 million for the same period in 2025, with the decrease due to lower personnel expense related to share-based compensation and salary expense and lower facility-related costs." exhibit
Q3 FY2026 "General and administrative expense was $7.2 million for the third quarter of 2026, compared with $6.8 million for the same period in 2025, with the increase primarily due to higher external expenses, including legal and other public company expenses and was partially offset by lower personnel expense related to share-based compensation." exhibit
Q3 FY2026 "Research and development expense was $28.8 million for the nine months ended September 30, 2026, compared with $33.8 million for the same period in 2025, with the decrease due to lower personnel expense related to share-based compensation and salary expense, lower external expenses primarily from certain antibody programs, and lower facility-related costs." exhibit
Q2 FY2026 "Document Exhibit 99.1 OmniAb Reports Second Quarter 2026 Financial Results and Business Highlights Raises Full Year 2026 Revenue and Cash Outlook Driven by Continued Business Momentum Conference Call to Begin Today at 4:30 p.m. ET EMERYVILLE, Calif." exhibit
Q2 FY2026 "(August 6, 2026) – OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today reported financial results for the three and six months ended June 30, 2026, provided operating and partner program progress, and updated 2026 financial guidance." exhibit
Q2 FY2026 "“We are pleased to report a strong quarter and to increase our revenue and cash outlook for 2026 based on continued momentum in our business." exhibit
Q2 FY2026 "Research and development expense was $9.6 million for the second quarter of 2026, compared with $10.9 million for the same period in 2025, with the decrease due to lower personnel expense related to share-based compensation and salary expense and lower facility-related costs." exhibit
Q2 FY2026 "General and administrative expense was $6.7 million for the second quarter of 2026, compared with $7.7 million for the same period in 2025, with the decrease primarily due to lower personnel expense related to share-based compensation and salary expense and lower professional fees." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/OABI
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/OABI

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

OABI earnings date badge

HTML

<a href="https://veritasdata.dev/company/OABI/"><img src="https://veritasdata.dev/embed/OABI.svg" alt="OABI earnings date" width="240" height="56"></a>

Markdown

[![OABI earnings date](https://veritasdata.dev/embed/OABI.svg)](https://veritasdata.dev/company/OABI/)

Script

<script async src="https://veritasdata.dev/embed/OABI.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/OABI"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.